Dr. Reddy's Laboratories Limited · NSE: DRREDDY · BSE: 500124
Dr. Reddy's Laboratories
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 22 Jul 2026.
Q1 FY27 · Consolidated
Revenue
8,099.80₹ Cr
−5.5% vs year ago
Net profit
435.60₹ Cr
−69.1% vs year ago
EPS, basic
5.33₹
−68.7% vs year ago
Net margin
5.4%
−11.1 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 8,099.80 | −5.5% | 435.60 | −69.1% | 5.33 | 22 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 7,546.40 | −11.5% | 221.30 | −86.1% | 2.65 | 12 May 2026 |
| Q3 FY26Oct–Dec 2025 | 8,753.40 | +4.4% | 1,189.60 | −15.3% | 14.53 | 21 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 8,828.30 | +9.8% | 1,336.80 | −0.4% | 16.18 | 24 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 8,572.10 | +11.4% | 1,409.90 | +1.3% | 17.04 | 23 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 8,528.40 | +19.9% | 1,586.70 | +21.1% | 19.12 | 09 May 2025 |
| Q3 FY25Oct–Dec 2024 | 8,381.20 | +15.8% | 1,404.20 | +1.7% | 16.97 | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 8,038.20 | +16.5% | 1,341.90 | −9.5% | 15.08 | 05 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 7,696.10 | +13.9% | 1,392.40 | −0.9% | 83.61 | 30 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 7,113.80 | +12.6% | 1,309.80 | +36.4% | 78.66 | 08 May 2024 |
| Q3 FY24Oct–Dec 2023 | 7,236.80 | +6.6% | 1,380.90 | +11.0% | 82.94 | 31 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 6,902.60 | +9.0% | 1,482.20 | +33.0% | 89.09 | 28 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 6,757.90 | +29.1% | 1,405.00 | +18.2% | 84.55 | 26 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 6,315.20 | +15.3% | 960.10 | +889.8% | 57.79 | 12 May 2023 |
| Q3 FY23Oct–Dec 2022 | 6,789.80 | +27.2% | 1,243.90 | +75.4% | 74.91 | 25 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 6,331.80 | +9.4% | 1,114.20 | +11.9% | 67.13 | 29 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 5,232.90 | +5.8% | 1,189.00 | +212.6% | 71.64 | 29 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 5,474.90 | +14.8% | 97.00 | −82.6% | 5.84 | 19 May 2022 |
| Q3 FY22Oct–Dec 2021 | 5,338.30 | +8.0% | 709.30 | 25x | 42.75 | 28 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 5,786.90 | +17.8% | 995.80 | +29.0% | 60.03 | 30 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 4,945.10 | +11.7% | 380.40 | −36.0% | 22.95 | 27 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 4,768.20 | +7.2% | 557.30 | −28.7% | 33.61 | 14 May 2021 |
| Q3 FY21Oct–Dec 2020 | 4,941.90 | +12.4% | 27.90 | Turned profit | 1.68 | 29 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 4,910.90 | +2.0% | 771.80 | −30.3% | 46.54 | 28 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 4,426.50 | +14.7% | 594.60 | −12.1% | 35.87 | 29 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 4,448.90 | +10.4% | 781.10 | +71.5% | 47.12 | 20 May 2020 |
| Q3 FY20Oct–Dec 2019 | 4,397.10 | +13.8% | (538.40) | Turned loss | (32.48) | 27 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 4,812.80 | +26.1% | 1,106.80 | +113.5% | 66.78 | 01 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 3,858.20 | +3.3% | 676.50 | +42.1% | 40.81 | 29 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 4,029.60 | — | 455.40 | — | 27.45 | 17 May 2019 |
| Q3 FY19Oct–Dec 2018 | 3,864.60 | — | 500.30 | — | 30.16 | 01 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 3,817.50 | — | 518.30 | — | 31.22 | 26 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 3,736.50 | — | 476.10 | — | 28.69 | 26 Jul 2018 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 5,136.60 | −34.2% | 404.70 | −86.3% | 4.86 | 22 Jul 2026 |
| Q4 FY26Jan–Mar 2026 | 3,822.00 | −31.3% | (219.40) | Turned loss | (2.63) | 12 May 2026 |
| Q3 FY26Oct–Dec 2025 | 4,282.70 | −14.6% | 90.60 | −89.3% | 1.09 | 21 Jan 2026 |
| Q2 FY26Jul–Sep 2025 | 4,618.60 | −31.0% | 387.30 | −79.4% | 4.65 | 24 Oct 2025 |
| Q1 FY26Apr–Jun 2025 | 7,809.50 | +33.7% | 2,961.20 | +108.9% | 35.59 | 23 Jul 2025 |
| Q4 FY25Jan–Mar 2025 | 5,562.90 | +9.0% | 1,200.70 | +16.0% | 14.41 | 09 May 2025 |
| Q3 FY25Oct–Dec 2024 | 5,015.00 | +22.2% | 849.40 | +78.7% | 10.20 | 24 Jan 2025 |
| Q2 FY25Jul–Sep 2024 | 6,696.30 | +38.4% | 1,882.10 | +57.8% | 22.60 | 05 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 5,841.20 | +7.4% | 1,417.20 | −13.6% | 85.10 | 30 Jul 2024 |
| Q4 FY24Jan–Mar 2024 | 5,104.80 | +12.1% | 1,034.80 | +53.9% | 62.14 | 08 May 2024 |
| Q3 FY24Oct–Dec 2023 | 4,103.00 | +5.3% | 475.20 | +46.4% | 28.55 | 31 Jan 2024 |
| Q2 FY24Jul–Sep 2023 | 4,838.70 | −0.9% | 1,192.60 | +6.8% | 71.68 | 28 Oct 2023 |
| Q1 FY24Apr–Jun 2023 | 5,437.30 | +49.8% | 1,639.40 | +228.2% | 98.66 | 26 Jul 2023 |
| Q4 FY23Jan–Mar 2023 | 4,554.00 | +24.1% | 672.40 | +60.2% | 40.49 | 12 May 2023 |
| Q3 FY23Oct–Dec 2022 | 3,897.60 | +12.0% | 324.60 | −4.8% | 19.54 | 25 Jan 2023 |
| Q2 FY23Jul–Sep 2022 | 4,880.30 | +27.6% | 1,116.30 | +148.6% | 67.25 | 29 Oct 2022 |
| Q1 FY23Apr–Jun 2022 | 3,630.60 | +5.7% | 499.50 | +20.8% | 30.10 | 29 Jul 2022 |
| Q4 FY22Jan–Mar 2022 | 3,668.70 | +9.5% | 419.70 | +34.7% | 25.29 | 19 May 2022 |
| Q3 FY22Oct–Dec 2021 | 3,479.60 | +2.1% | 341.10 | −23.1% | 20.55 | 28 Jan 2022 |
| Q2 FY22Jul–Sep 2021 | 3,823.40 | +14.3% | 449.00 | −6.7% | 27.07 | 30 Oct 2021 |
| Q1 FY22Apr–Jun 2021 | 3,433.50 | +5.8% | 413.40 | −56.5% | 24.94 | 27 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 3,350.70 | +17.5% | 311.50 | −38.0% | 18.78 | 14 May 2021 |
| Q3 FY21Oct–Dec 2020 | 3,408.20 | +12.0% | 443.70 | −15.0% | 26.74 | 29 Jan 2021 |
| Q2 FY21Jul–Sep 2020 | 3,345.80 | −2.9% | 481.00 | −64.8% | 29.00 | 28 Oct 2020 |
| Q1 FY21Apr–Jun 2020 | 3,244.40 | +29.3% | 950.20 | +73.4% | 57.31 | 29 Jul 2020 |
| Q4 FY20Jan–Mar 2020 | 2,851.70 | +7.8% | 502.80 | +147.9% | 30.34 | 20 May 2020 |
| Q3 FY20Oct–Dec 2019 | 3,044.00 | +11.4% | 521.70 | +30.6% | 31.47 | 27 Jan 2020 |
| Q2 FY20Jul–Sep 2019 | 3,446.00 | +31.0% | 1,365.10 | +294.3% | 82.36 | 01 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 2,508.70 | −4.2% | 548.10 | +66.6% | 33.06 | 29 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 2,645.20 | — | 202.80 | — | 12.22 | 17 May 2019 |
| Q3 FY19Oct–Dec 2018 | 2,731.70 | — | 399.40 | — | 24.08 | 01 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 2,631.00 | — | 346.20 | — | 20.86 | 26 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 2,617.60 | — | 328.90 | — | 19.82 | 26 Jul 2018 |
66 filings on record for this company.